SCHEMBL24937762

SCHEMBL24937762

O=C(N1CCOCC1)n1nccn1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.52
TP53 P04637 1/20 0.52
KMT2A Q03164 1/20 0.52
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
AKR1C3 P42330 6/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.42
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24937188 0.80 ALDH1A1 (0.50) MEN1TP53KMT2AALDH1A1HPGD
SCHEMBL17761098 0.78 ALDH1A1 (0.54) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL2899860 0.77 MEN1 (0.80) MEN1TP53KMT2AAKR1C3CYP2C9
SCHEMBL11741744 0.74 MEN1 (0.85) MEN1TP53KMT2AAKR1C3CYP2C9
Hydrochloric Acid SCHEMBL27660773 0.74 MEN1 (0.76) MEN1TP53KMT2AAKR1C3CYP2C9
Hydrochloric Acid SCHEMBL28000052 0.74 MEN1 (0.76) MEN1TP53KMT2AAKR1C3CYP2C9
SCHEMBL19078739 0.73 MEN1 (0.46) MEN1TP53KMT2AKDM4EALDH1A1
SCHEMBL11029882 0.72 MEN1 (0.48) MEN1TP53KMT2AKDM4EALDH1A1
SCHEMBL1018407 0.71
SCHEMBL4240780 0.71 MEN1 (0.47) MEN1TP53KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024778-A1 STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND THE UNIVERSITY OF TOKYO (JP) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024778-A1 STRIGOLACTONE RECEPTOR INHIBITOR, AGRICULTURAL COMPOSITION AND USE THEREOF, STRIGA SEED GERMINATION INHIBITOR, AND TRIAZOLE UREA COMPOUND UTS2R, TAS1R1, ULK3 MEN1 4204/4885TP53 3919/4885KMT2A 3299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.